Idiopathic (autoimmune) thrombocytopenic purpura (ITP) typically presents with which of the following?

Study for the PANCE Precision Exam. Improve with flashcards and multiple choice questions, each question has hints and explanations. Get ready for your exam!

Multiple Choice

Idiopathic (autoimmune) thrombocytopenic purpura (ITP) typically presents with which of the following?

Explanation:
ITP is an autoimmune process where antibodies target platelets, leading to a low platelet count and a tendency to bleed. The classic presentation is mucocutaneous bleeding—petechiae, easy bruising, and sometimes nose or gum bleeding—without enlargement of the spleen. Many patients feel otherwise well, so they can be asymptomatic aside from these bleeding signs. Coagulation studies are usually normal because the problem is platelet number, not clotting factor defects. The spleen isn’t enlarged because the issue is destruction of platelets, not sequestration or infiltration. Intracranial hemorrhage can occur but is rare and indicates severe thrombocytopenia rather than the typical starting picture. Splenectomy is not done immediately; it’s reserved for chronic, refractory cases after medical therapy has been tried.

ITP is an autoimmune process where antibodies target platelets, leading to a low platelet count and a tendency to bleed. The classic presentation is mucocutaneous bleeding—petechiae, easy bruising, and sometimes nose or gum bleeding—without enlargement of the spleen. Many patients feel otherwise well, so they can be asymptomatic aside from these bleeding signs. Coagulation studies are usually normal because the problem is platelet number, not clotting factor defects. The spleen isn’t enlarged because the issue is destruction of platelets, not sequestration or infiltration. Intracranial hemorrhage can occur but is rare and indicates severe thrombocytopenia rather than the typical starting picture. Splenectomy is not done immediately; it’s reserved for chronic, refractory cases after medical therapy has been tried.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy